While research suggests potential advantages, its equally important to acknowledge the limited data on long-term effects in humans and the FDAs categorization of ipamorelin as a 503A/503B drug
Steven Vasilev, a board-certified integrative gynecologic oncologist and medical director of Integrative Gynecologic Oncology at Providence Saint Johns Health Center, professor at Saint Johns Cancer Institute in Santa Monica, CA, not involved in this study, explained for Medical News Today : Endometriosis in monkeys closely simulates [the] behavior of human endometriosis, making this an excellent model. In this study, the researchers used monkeys with spontaneous endometriosis and others with endometriosis induced by transplanting endometrial tissue into the The researchers developed an antibody AMY109 that binds to IL-8
Ipamorelin may support body-composition goals indirectly through growth hormone signaling, but it has less direct weight-loss evidence than GLP-1s or Tesamorelin
Semaglutide or Tirzepatide + Tesamorelin Users without access to Retatrutide might consider stacking Tesamorelin with available GLP-1 medications
As of mid-2026, neither cagrilintide nor retatrutide is FDA- or EMA-approved for any indication, and no legitimate prescription product exists for either
